Spatial Analysis of Global Variability in Covid-19 Burden
| Autor: | Anna L Miller, Larry E. Miller, Ruemon Bhattacharyya |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
education.field_of_study Coronavirus disease 2019 (COVID-19) Descriptive statistics 030503 health policy & services Health Policy Public health Incidence (epidemiology) Population Public Health Environmental and Occupational Health Prevalence 03 medical and health sciences 0302 clinical medicine Geography Case fatality rate San Marino medicine 030212 general & internal medicine 0305 other medical science education Demography |
| Zdroj: | Risk Management and Healthcare Policy. 13:519-522 |
| ISSN: | 1179-1594 |
| DOI: | 10.2147/rmhp.s255793 |
| Popis: | Background Since the first occurrence of coronavirus disease 2019 (Covid-19), a number of online tools have become available to assist with tracking Covid-19 prevalence. Yet we are unaware of resources that provide country-specific Covid-19 incidence data. Methods We undertook a descriptive analysis of the global impact of Covid-19 using data reported on March 17, 2020. The prevalence of Covid-19 cases, fatalities attributed to Covid-19, and the case fatality rate for each of the 238 countries were accessed from the World Health Organization global Covid-19 tracking site, and we additionally calculated Covid-19 incidence based on country-specific population data. We determined the country-specific point prevalence and incidence of Covid-19 and associated deaths while using geocoded data to display their spatial distribution with geographic heat maps. Results The analysis included 193,197 Covid-19 cases and 7859 associated deaths. The point prevalence was highest in China (80,881), Italy (31,506), Iran (16,169), and Spain (11,312); no other country reported more than 10,000 cases. The incidence (per million population) was highest in San Marino (3389) followed by Iceland (645) and Italy (521); no other country had an incidence above 400 per million population. Conclusion Countries with a high Covid-19 prevalence may not have a high incidence, and vice versa. Public health agencies that provide real-time infection tracking tools should report country-specific Covid-19 incidence metrics, in addition to prevalence data. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|